Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |